A humanized chimera antibody, a pharmaceutical composition comprising a humanized chimera antibody and a pharmaceutically acceptable carrier, and a method of treating cancer which comprises administering to a patient a pharmaceutically acceptable amount of said humanized chimera antibody, are disclosed.

 
Web www.patentalert.com

< Methods and compositions for highly efficient transformation of filamentous fungi

< Anti-C2/C2a inhibitors of complement activation

> Polypeptides of the "basic helix-loop-helix" bHLH family, corresponding nucleic acid sequences

> Recombinant infectious laryngotracheitis virus and uses thereof
~ 00220